RNLS and heart failure: Finally, we will evaluate the extensive data on circulating renalase levels as a potential clinical biomarker across a spectrum of conditions, including hypertension, coronary artery disease, atrial fibrillation, and heart failure, also considering its correlation with broader cardiovascular risk factors and outcomes.